About the Phase 3 KINECT®-DCP Study The Phase 3, randomized, double-blind, placebo-controlled study was designed to evaluate the efficacy, safety and tolerability of valbenazine for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback